Cart
sales@molnova.com
Zaurategrast
CAS No. 455264-31-0
Zaurategrast( CDP-323 | CDP 323 | CDP323 )
Catalog No. M14541 CAS No. 455264-31-0
A potent and selective, orally bioavailable α4 integrin (α4β1/VLA-4 and, to a lesser extent, α4β7 integrin) antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 789 | Get Quote |
|
| 100MG | 1197 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameZaurategrast
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective, orally bioavailable α4 integrin (α4β1/VLA-4 and, to a lesser extent, α4β7 integrin) antagonist.
-
DescriptionA potent and selective, orally bioavailable α4 integrin (α4β1/VLA-4 and, to a lesser extent, α4β7 integrin) antagonist, an ester prodrug of CT-7758; is developed for the treatment of multiple sclerosis.Multiple Sclerosis Phase 2 Discontinued.
-
In VitroZaurategrast (CT7758) is a carboxylate containing α4β1/α4/β7 integrin antagonist.
-
In Vivo——
-
SynonymsCDP-323 | CDP 323 | CDP323
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research AreaInflammation/Immunology
-
IndicationMultiple Sclerosis
Chemical Information
-
CAS Number455264-31-0
-
Formula Weight521.4057
-
Molecular FormulaC26H25BrN4O3
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(O)[C@@H](NC1=C(Br)C(C12CCCCC2)=O)CC3=CC=C(NC4=NC=CC5=C4C=NC=C5)C=C3
-
Chemical NameL-Phenylalanine, N-(2-bromo-3-oxospiro[3.5]non-1-en-1-yl)-4-(2,7-naphthyridin-1-ylamino)- (9CI)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bailey, et al. Current Immunology Reviews, 2012, 8, 135-1402. Wolf C, et al. PLoS One. 2013;8(3):e58438.
3. Chanteux H, et al. Drug Metab Dispos. 2014 Jan;42(1):153-61.
molnova catalog
related products
-
ICAM-1-IN-1
ICAM-1-IN-1 is a potent and selective E-selectin(IC50 = 7 nM) and ICAM-1(IC50 = 5 nM) inhibitor.
-
Bersanlimab
Bersanlimab (BI-505) is a fully human monoclonal antibody targeting Intercellular Adhesion Molecule-1 (ICAM-1), demonstrating anticancer properties and applicable for studying relapsed/refractory multiple myeloma.
-
Gambogic Acid
Gambogic Acid ( EC50=0.78-1.64 uM) activates caspases. Gambogic Acid competitively suppresses Bcl-XL, Bcl-2, Bcl-W, Bcl-B, Bfl-1 and Mcl-1.
